| Identification | Back Directory | [Name]
C17 3'-sulfo Galactosylceramide (d18:1/17:0) | [CAS]
1071654-84-6 | [Synonyms]
C17 3&rsquo
N-Heptadecanoyl-sulfatide
-sulfo Galactosylceramide (d18:1/17:0)
C17 3'-sulfo Galactosylceramide (d18:1/17:0)
N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-heptadecanamide
Heptadecanamide, N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]- | [Molecular Formula]
C41H79NO11S | [MOL File]
1071654-84-6.mol | [Molecular Weight]
794.14 |
| Chemical Properties | Back Directory | [density ]
1.13±0.1 g/cm3(Predicted) | [solubility ]
Chloroform:Methanol (2:1): soluble; DMF: soluble; DMSO: soluble | [form ]
A solid | [pka]
-3.61±0.18(Predicted) |
| Hazard Information | Back Directory | [Description]
C17 3''-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. C17 3''-sulfo Galactosylceramide has been used as an internal standard for the quantification of sulfatides in urine and blood samples from patients with metachromatic leukodystrophy, a disorder characterized by arylsulfatase A deficiency, leading to sulfatide accumulation. [Matreya, LLC. Catalog No. 1934] | [References]
[1] YANLI CUI. Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies[J]. Glycoconjugate Journal, 2007, 25 1: 145. DOI: 10.1007/s10719-007-9072-x |
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Website: |
https://www.alfa-chemistry.com |
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Website: |
www.enzo.com |
|